BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 10, 2004
View Archived Issues
Labopharm to formulate once-daily trazodone
Read More
Novel steroid sulphate inhibitor for breast tumor therapy reported
Read More
NNC-55-0396: A novel selective T-type Ca2+ channel inhibitor
Read More
Promising ORL-1 antagonist for chronic pain therapy
Read More
Novel NPY Y1 inhibitor from Bristol-Myers Squibb
Read More
Early access program for pirfenidone in IPF
Read More
Payment to NeuroSearch for ongoing development of NS-2330
Read More
Zambon and BioXell to develop new CXCR3 antagonists
Read More
Enrollment under way in ARRIVE registry program
Read More
Micrologix Biotech acquires celgosivir rights
Read More
Positive results for Columbia's lidocaine vaginal gel for dysmenorrhea
Read More
BioTie Therapies reports 2003 progress
Read More
Celgene reports 2003 company highlights
Read More
BMS highlights 2003 development activities
Read More
Novel cannabinoid CB2 agonists and their use reported by Schering-Plough
Read More
Merck Frosst presents PDE4 inhibitors for cognition disorders, asthma, etc.
Read More
Pfizer presents new ERbeta-selective SERM in a recent patent
Read More
Celltech team identifies a novel series of p38 MAP kinase inhibitors
Read More
Novel antimalarial agents in early development at Merck
Read More
New PPAR agonists and their use reported by GSK researchers
Read More
Acutumine and its derivatives exhibit cognition-enhancing properties
Read More
Enrollment ceased in phase III NSCLC study of Sarasar
Read More
Extension to Vitrase NDA review
Read More
Probactrix IBS trial commences enrollment
Read More
Chinese approval for phase I trial of Sinovac's SARS vaccine candidate
Read More
Neuroprotective effects of GPI-15427 following cardiac arrest
Read More
Long therapeutic window for neuroprotection with highly selective kappa-opioid receptor agonists
Read More
A 2% green tea extract gel significantly improves damaged and aged facial skin in women
Read More
Effective treatment of psychodermatoses with an antidepressant
Read More
Therapeutic benefits found for botulinum toxin type A in hyperhidrosis
Read More
Phase II results of a G17-DT combination therapy in advanced gastric cancer
Read More